Research Fellow
The Lundquist Institute
Summary
Multiple postdoctoral research positions are available in the Yoshihara Laboratory at The Lundquist Institute at Harbor-UCLA Medical Center. Our laboratory investigates the molecular mechanisms underlying pancreatic β cell development, function, regeneration, and immune interactions, with the ultimate goal of developing innovative therapies for type 1 and type 2 diabetes. We integrate human pluripotent stem cell-derived islets, genetically engineered mouse models, multi-omics technologies, and AI-driven approaches to understand β-cell biology and develop new strategies for regenerative medicine.
Job description
Description of Duties
Multiple postdoctoral research positions are available in the Yoshihara Laboratory at The Lundquist Institute at Harbor-UCLA Medical Center. Our laboratory investigates the molecular mechanisms underlying pancreatic β cell development, function, regeneration, and immune interactions, with the ultimate goal of developing innovative therapies for type 1 and type 2 diabetes. We integrate human pluripotent stem cell-derived islets, genetically engineered mouse models, multi-omics technologies, and AI-driven approaches to understand β-cell biology and develop new strategies for regenerative medicine.
Research Areas
- Stem Cell Biology and Regenerative Medicine: Improving the differentiation, functional maturation, and scalability of human pluripotent stem cell-derived pancreatic islets.
- β-Cell Development and Regeneration: Investigating molecular mechanisms regulating β-cell proliferation, identity, and functional maturation using genetic and disease mouse models.
- Immunology and Diabetes: Understanding β-cell inflammatory responses, epigenetic memory and developing immune-resilient stem cell-derived islets for transplantation.
- Whole body metabolic regulation: Investigating how the organs orchestrate to regulate whole body glucose and lipid homeostasis through nuclear receptor signaling.
- Multi-Omics and Computational Biology: Integrating single-cell transcriptomics, epigenomics, proteomics, and computational approaches to identify novel therapeutic targets.
- AI-Driven Stem Cell Research: Developing machine learning-based approaches for label-free assessment and quality control of stem cell-derived pancreatic islets.
Qualifications
We seek highly motivated and independent candidates who have recently obtained or are nearing completion of a Ph.D., M.D./Ph.D., or M.D. degree.
- A strong background in molecular biology, cell biology, developmental biology, stem cell biology, immunology, or related fields.
- Experience with human pluripotent stem cells, mouse models, next-generation sequencing, and/or multi-omics analyses is preferred.
- A strong publication record demonstrating scientific productivity.
- Excellent communication, organizational, and collaborative skills.
- Enthusiasm for pursuing innovative and translational research.
- Experience in computational biology, bioinformatics, or machine learning is an advantage but is not required.
Requirements
- Recently obtained or nearing completion of a Ph.D., M.D./Ph.D., or M.D. degree
- Strong background in molecular biology, cell biology, developmental biology, stem cell biology, immunology, or related fields
- Strong publication record demonstrating scientific productivity
- Excellent communication, organizational, and collaborative skills
- Enthusiasm for pursuing innovative and translational research
- Experience with human pluripotent stem cells, mouse models, next-generation sequencing, and/or multi-omics analyses preferred
- Experience in computational biology, bioinformatics, or machine learning is an advantage but not required
Benefits
- Full-time benefits
Company overview
The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (TLI) is a leading nonprofit biomedical research organization founded in 1952 by visionary physicians seeking better treatments for their patients. Operating with a unique "bedside to bench to bedside" approach, TLI translates clinical challenges into scientific inquiry and discoveries back into patient care. The institute employs over 150 principal investigators and more than 550 research staff who conduct over 600 active studies annually, including approximately 130 clinical trials. Affiliated with the David Geffen School of Medicine at UCLA and partnered with Harbor-UCLA Medical Center, TLI focuses on cutting-edge translational research across multiple domains including cancer biology, respiratory medicine, infectious diseases, translational genomics, and metabolic disorders. The organization also operates extensive community health programs serving over 60,000 underserved women and children monthly in Los Angeles County, promoting health equity while fostering the next generation of scientific leaders through robust education and training programs.